Recro Pharma
REPH
#9472
Rank
โ‚ฌ0.11 B
Marketcap
1,91ย โ‚ฌ
Share price
-0.48%
Change (1 day)
-24.74%
Change (1 year)

Earnings for Recro Pharma (REPH)

Earnings in 2021 (TTM): โ‚ฌ3.19 Million

According to Recro Pharma 's latest financial reports the company's current earnings are โ‚ฌ75.36 Million. In 2020 the company made an earning of -โ‚ฌ7.58 Million a decrease over its 2019 earnings that were of โ‚ฌ22.27 Million.

Earnings history for Recro Pharma from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)โ‚ฌ3.19 M-142.21%
2020-โ‚ฌ7.58 Million-134.02%
2019โ‚ฌ22.27 M-145.64%
2018-โ‚ฌ48.8 Million34.08%
2017-โ‚ฌ36.4 Million55.21%
2016-โ‚ฌ23.45 Million258.83%
2015-โ‚ฌ6.54 Million-39.6%
2014-โ‚ฌ10.82 Million989.11%
2013-โ‚ฌ1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B 497,269.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚ฌ16.08 M 368.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚ฌ72.38 Million-2,209.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚ฌ9.38 Million-373.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚ฌ57.25 Million-1,768.23%๐Ÿ‡บ๐Ÿ‡ธ USA